Count of breast implants rise due to significance towards physical appearance

Medical - Mohit Shah - Jun 13,2017

Rating -

stars - based on 21 reviews

count of breast implants rise due to significance towards physical appearance

The global breast implants market is anticipated to rise at an impressive CAGR of 4.1% between 2016 and 2024, with a valuation of US$ 1,482.1 million.

Breast implants are basically medical devices which consist of an outer silicone shell as well as a filler, more commonly silicone gel or saline (sterile water). It has been analyzed that, greater emphasis on physical appearance has eventually led to a growing number of breast augmentation procedures primarily in developed countries such as the U.S., Mexico, Brazil, and Colombia. 

As per a recent research report added by Market Research Reports Search Engine (MRRSE), the breast implants market on the global level is anticipated to surge at a CAGR of 4.1% between 2016 and 2024. At this pace, the market might acquire a valuation of US$ 1,482.1 million by the end of the stated period.

Currently, the quickly aging baby boomer population along with an increased focus on their physical appearance merged with wider availability of highly cohesive silicone breast implants are seen as important factors which are likely to enhance the growth of the worldwide breast implants market. Moreover, it has been analyzed that a large number of women are picking breast implants during their reproductive ages, and this aspect has concluded in more number of breast augmentation procedures on the global scenario.

However, there are various risk factors involved such as serious complications including deflation, infection, capsular contracture and breast and nipple sensitivity. Also, high costs of the implant procedure are expected to restrain the development of the global breast implants market.

The top companies dominating the breast implants market include GC Aesthetics Plc., Mentor Worldwide LLC., Sientra Inc., Polytech Health & Aesthetics GmbH, Allergan Plc., Groupe Sebbin SAS, HansBiomed Co. Lt and Establishment Labs S.A.

 

For more information on this report visit- http://www.mrrse.com/breast-implant-market